We are live on
!
Find out more
PI
Putnam Investments Portfolio holdings
AUM
$75.7B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+11.86%
1 Year Est. Return
+34.45%
3 Year Est. Return
+61.95%
5 Year Est. Return
+203.43%
10 Year Est. Return
+442.91%
AUM
$41.6B
AUM Growth
+$4.2B
(+11%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
0.41%
Top 10 Holdings %
Top 10 Hldgs %
15.94%
Holding
1,599
New
148
Increased
483
Reduced
778
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$242M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$183M |
| 3 |
ExxonMobil
XOM
|
+$176M |
| 4 |
Western Digital
WDC
|
+$176M |
| 5 |
Micron Technology
MU
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
+$189M |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
JPMorgan Chase
JPM
|
+$134M |
| 4 |
LyondellBasell Industries
LYB
|
+$126M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.21% |
| 2 | Financials | 15.23% |
| 3 | Technology | 11.4% |
| 4 | Communication Services | 10.87% |
| 5 | Consumer Discretionary | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
1126
DELISTED
Molecular Templates, Inc.
MTEM
| $1.04M | ﹤0.01% |
+1,354
| New | +$1.02M |
|
|
ALXN
1127
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.04M | ﹤0.01% |
7,800
+484
| +7% | +$58.1K |
|
1128
Boston Scientific
BSX
$71.5B
| $1.03M | ﹤0.01% |
86,084
+6,168
| +8% | +$72.9K |
|
|
LOCK
1129
DELISTED
LifeLock, Inc.
LOCK
| $1.03M | ﹤0.01% |
+62,640
| New | +$987K |
|
1130
PTC Therapeutics
PTCT
$6.12B
| $1.02M | ﹤0.01% |
60,000
| – | – |
|
|
POLY
1131
DELISTED
Plantronics, Inc.
POLY
| $1.02M | ﹤0.01% |
21,879
-302
| -1% | -$13.6K |
|
|
NBL
1132
DELISTED
Noble Energy, Inc.
NBL
| $1.02M | ﹤0.01% |
14,926
-801,073
| -98% | -$56.7M |
|
|
ASCMA
1133
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $1.02M | ﹤0.01% |
11,869
-180
| -1% | -$15.2K |
|
|
VOCS
1134
DELISTED
VOCUS INC
VOCS
| $1.01M | ﹤0.01% |
+89,111
| New | +$858K |
|
|
ARRY
1135
DELISTED
Array Biopharma Inc
ARRY
| $1M | ﹤0.01% |
200,514
-685,849
| -77% | -$3.73M |
|
1136
Semtech
SMTC
$13B
| $1M | ﹤0.01% |
39,543
-694
| -2% | -$20.5K |
|
|
SGI
1137
DELISTED
Silicon Graphics Intl.
SGI
| $1M | ﹤0.01% |
74,536
-847
| -1% | -$11.4K |
|
|
MPT
1138
Medical Properties Trust
MPT
$2.81B
| $992K | ﹤0.01% |
81,162
-10,863
| -12% | -$139K |
|
|
HES
1139
DELISTED
Hess
HES
| $989K | ﹤0.01% |
11,920
-88,238
| -88% | -$7.17M |
|
|
SAAS
1140
DELISTED
inContact, Inc.
SAAS
| $989K | ﹤0.01% |
+126,632
| New | +$964K |
|
1141
Franklin Resources
BEN
$17.2B
| $976K | ﹤0.01% |
16,899
+600
| +4% | +$32.3K |
|
|
FTR
1142
DELISTED
Frontier Communications Corp.
FTR
| $971K | ﹤0.01% |
13,930
-84
| -0.6% | -$5.75K |
|
1143
Crown Castle
CCI
$32.2B
| $967K | ﹤0.01% |
13,169
+2,069
| +19% | +$153K |
|
1144
Air Products & Chemicals
APD
$67.6B
| $962K | ﹤0.01% |
9,303
+540
| +6% | +$54.4K |
|
|
GK
1145
DELISTED
G&K Services Inc
GK
| $962K | ﹤0.01% |
15,459
-18,928
| -55% | -$1.14M |
|
1146
Matsons
MATX
$6.18B
| $952K | ﹤0.01% |
+36,427
| New | +$937K |
|
|
ECOL
1147
DELISTED
US Ecology, Inc.
ECOL
| $952K | ﹤0.01% |
+25,618
| New | +$886K |
|
1148
Devon Energy
DVN
$47.3B
| $950K | ﹤0.01% |
15,362
+675
| +5% | +$41.4K |
|
|
SFY
1149
DELISTED
SWIFT ENERGY CO (HOLDING COMPANY)
SFY
| $946K | ﹤0.01% |
70,045
+3,202
| +5% | +$42.2K |
|
|
NXTM
1150
DELISTED
NxStage Medical Inc.
NXTM
| $945K | ﹤0.01% |
94,446
-1,389
| -1% | -$15.8K |
|
Similar funds
MGIM
BC
WMSA
SS
PMEF
CC
GW
GC
Putnam Investments's Q4 2013 Portfolio in Review
As of Q4 2013, Putnam Investments held 1,599 positions worth $41.6B, up 11% from $37.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Putnam Investments's Q4 2013 filing shows 148 new, 483 increased, 778 reduced and 140 closed positions. Its largest new stake was Liberty Global Class A: 2,312,744 shares worth $84.9M. The largest sale was VIROPHARMA INC, an estimated $189M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
- Putnam Investments's largest Q4 2013 buy was Liberty Global Class A: 2,312,744 shares worth $84.9M.
- Putnam Investments added most to Jazz Pharmaceuticals in Q4 2013, an estimated $242M increase.
- Putnam Investments's biggest Q4 2013 reduction was Apple, cutting an estimated $136M.
- Putnam Investments fully exited VIROPHARMA INC in Q4 2013, selling an estimated $189M.
- Putnam Investments's ten largest holdings make up 16% of its $41.6B portfolio in Q4 2013.
- Putnam Investments opened 148 new positions and closed 140 in Q4 2013.
- Putnam Investments's portfolio value rose 11% quarter-over-quarter to $41.6B.
Based on Putnam Investments's 13F filing for Q4 2013, filed 13 Feb 2014.